// App-Quantinova.ai

: [155] Untuned antiviral immunity in COVID-19 revealed by temporal type I/III 1 interferon patterns and flu comparison

Researchers

Presenter

  • Nikoletta Rovina

Principal Investigators

  • Ioanna-Evdokia Galani

  • Vicky Lampropoulou

  • Vasiliki Triantafyllia

  • Maria Manioudaki

  • Eleftherios Pavlos

  • Evangelia Koukaki

  • Paraskevi C. Fragkou

  • Vasiliki Panou

  • Vasiliki Rapti

  • Ourania Koltsida

  • Andreas Mentis

  • Nikolaos Koulouris

  • Sotirios Tsiodras

  • Antonia Koutsoukou

  • Evangelos Andreakos

Medical Centers

  • ICU, 1st Department of Respiratory Medicine, National and Kapodistrian University of Athens, Medical School, ‘Sotiria’ General Hospital of Chest Diseases, Athens, Greece

  • Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece

  • ICU, 1st Department of Respiratory Medicine, National and Kapodistrian University of Athens, Medical School, ‘Sotiria’ General Hospital of Chest Diseases, Athens, Greece

  • th Department of Internal Medicine, Attikon University Hospital, University of Athens Medical School, Athens, Greece

  • nd Respiratory Clinic, ‘Sotiria’ General Hospital of Chest Diseases, Athens, Greece

  • Microbiology, Hellenic Pasteur Institute, Athens, Greece

  • Airway Disease Infection Section, National Heart and Lung Institute (NHLI), Imperial College London, London, United Kingdom.

Locations

  • Greece

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • Interleukin-8

  • Interleukin 6

  • Tumor necrosis factor

Drug/Treatment

  • Interferon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved